Mar-08 -

Gastro-Intestinal Group

EORTC 40983 – Pre-and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV versus Surgery alone in Resectable Liver Metastases from Colorectal Origin- Phase III Study

EORTC found that in patients with resectable liver metastases from colorectal cancer, the perioperative chemotherapy with FOLFOX4, resulted in progression free survival. The study set a new international standard of care in patients who are candidates for removal of liver metastases caused by colorectal cancer (CRC).


Go to Top